Tung Kelly, Rosenthal Allison C, Craig Fiona E, Ashman Jonathan B, Yang Ming
Department of Radiology, Mayo Clinic Arizona, Scottsdale, Arizona.
Department of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona.
J Nucl Med Technol. 2018 Dec;46(4):396-397. doi: 10.2967/jnmt.118.212274. Epub 2018 Jun 8.
We present serial F-FDG PET/CT findings in a case of grade 3 pulmonary lymphomatoid granulomatosis positive for the Epstein-Barr virus. The patient experienced a transient complete response to R-CHOP chemotherapy and subsequent multisystem recurrence, predominately involving the subcutaneous region of the torso on F-FDG PET/CT. Biopsy of the most hypermetabolic subcutaneous lesion demonstrated grade 1 cutaneous lymphomatoid granulomatosis negative for the Epstein-Barr virus. This report highlights the role of F-FDG PET/CT in characterizing and monitoring disease progression and regression, as well as the limitations of F-FDG PET/CT in accurate grading of multisystem recurrence, given the diversity of clinical and histopathologic features of lymphomatoid granulomatosis.
我们展示了1例EB病毒阳性的3级肺淋巴瘤样肉芽肿病患者的系列F-FDG PET/CT检查结果。该患者对R-CHOP化疗有短暂的完全缓解,随后出现多系统复发,在F-FDG PET/CT上主要累及躯干皮下区域。对代谢最活跃的皮下病变进行活检,结果显示为1级皮肤淋巴瘤样肉芽肿病,EB病毒阴性。本报告强调了F-FDG PET/CT在疾病特征描述及监测疾病进展和缓解方面的作用,同时鉴于淋巴瘤样肉芽肿病临床和组织病理学特征的多样性,也指出了F-FDG PET/CT在多系统复发准确分级方面的局限性。